Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Topical treatments led to hair regrowth in a man with linear morphea.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.